Skip to main content
. 2016 Oct 17;20(6):569–575. doi: 10.1016/j.bjid.2016.09.004

Table 3.

Univariate analysis of sociodemographic, clinical and sexual behavior-related risk factors for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infection in 498 people living with HIV, in Salvador, Brazil.

Men
Women
Urogenital CT/NG (n = 6)
Anorectal CT/NG (n = 27)
Endocervical CT/NG (n = 11)
Anorectal CT/NG (n = 17)
n (%) p OR 95% CI n (%) p OR 95% CI n (%) p OR 95% CI n (%) p OR 95% CI
Socio-demographic
 Age ≤29 years old 2 (3.8) .669 1.32 0.24–7.45 12 (22.6) .023 2.61 1.12–6.10 8 (10.8) .001 9.21 2.38–35.71 11 (14.9) .000 6.55 6.33–18.40
 Single 4 (2.7) .652 0.62 0.12–3.31 21 (14.3) .832 1.11 0.42–2.95 5 (3.1) .630 0.76 0.23–2.54 11 (6.9) .285 1.73 0.63–4.82
 White ethnicity 2 (6.7) .235 2.84 0.50–16.25 7 (23.3) .108 2.18 0.82–5.72 1 (4.5) .567 1.30 0.16–10.65 3 (13.6) .114 3.03 0.80–11.48
 Less than 8 schooling years 0 (0.0) 1.000 1.04 1.01–1.07 2 (8.7) .748 0.55 0.12–2.50 8 (7.3) .020 5.10 1.32–19.63 7 (6.4) .630 1.27 0.47–3.46
 Monthly income ≤2 MWa 3 (2.9) 1.000 0.87 0.17–4.42 15 (14.7) .809 1.11 0.49–2.51 11 (4.4) .222 0.96 0.93–0.98 14 (5.6) 1.000 0.98 0.27–3.54
 Pregnant women 6 (18.8) .000 12.37 3.53–43.31 5 (15.6) .023 4.03 1.32–12.30
 Alcohol use 5 (3.5) 1.000 1.73 0.20–15.15 22 (15.3) .376 1.59 0.57–4.45 3 (1.8) .120 0.30 0.08–1.16 8 (4.8) .530 0.73 0.27–1.95
 Tobacco use 2 (4.8) .614 1.83 0.32–10.33 6 (14.3) .962 1.02 0.39–2.73 0 (0.0) .608 1.04 1.02–1.07 1 (3.4) 1.000 0.58 0.07–4.51
 Drug use 2 (3.8) .661 1.37 0.24–7.71 9 (17.3) .420 1.43 0.60–3.42 3 (7.0) .191 2.38 0.60–9.35 1 (2.3) .483 0.37 0.05–2.83



Sex-risk behaviors
 Lifetime sexual partners >3 2 (66.6) .092 18.20 1.41–235.34 2 (66.6) .370 3.10 0.27–35-38 6 (3.0) .409 1.66 0.50–5.57 9 (4.5) .237 1.80 0.67–4.80
 Irregular condom use 2 (4.8) .614 1.83 0.32–10.32 7 (16.7) .583 1.30 0.51–3.32 3 (3.0) 1.000 0.75 0.19–2.88 3 (3.0) .194 0.41 0.12–1.47
 Alcohol before sex 3 (3.3) 1.000 1.13 0.22–5.72 17 (18.7) .076 2.11 0.91–4.89 1 (0.8) .031 0.14 0.02–1.09 6 (4.9) .631 0.78 0.28–2.16
 Drug before sex 1 (3.1) 1.000 1.01 0.11–8.92 4 (12.5) 1.000 0.86 0.28–2.67 1 (4.3) .584 1.24 0.15–10.11 1 (4.3) 1.000 0.76 0.10–5.97
 Transactional sex 0 (0.0) 1.000 1.04 1.01–1.07 2 (10.5) 1.000 0.70 0.15–3.22 2 (7.2) .267 2.29 0.47–11.17 1 (3.6) 1.000 0.60 0.08–4.73
 Anal receptive intercourse 5 (3.0) .585 0.77 0.09–6.88 27 (16.2) .029 0.84 0.78–0.90 4 (2.1) .108 0.33 0.09–1.14 12 (6.3) .485 1.46 0.50–4.26
 Previous STI 6 (3.6) 1.000 0.96 0.94–0.99 26 (15.6) .136 4.61 0.60–35.53 6 (4.0) .734 1.23 0.39–4.13 6 (4.0) .228 0.54 0.19–1.49



Patient complaints
 Anal fissureb 2 (3.4) 1.000 1.12 0.20–6.31 10 (16.9) .456 1.38 0.59–3.23
 Pain in anal intercourse 2 (4.0) .676 1.28 0.23–7.23 12 (24.0) .028 2.55 1.09–5.99
 Dyspareunia 3 (4.5) .706 1.36 0.33–5.62 5 (7.6) .696 1.24 0.42–3.73
 Genital discharge 1 (16.7) .178 7.12 0.70–72.72 1 (16.7) .594 1.26 0.14–11.27 6 (5.5) .188 2.21 0.66–7.43 9 (8.3) .131 2.10 0.79–5.62
 Genital ulcer 1 (4.0) .570 1.36 0.15–12.13 6 (24.0) .122 2.21 0.79–6.16 0 (0.0) 1.000 1.04 1.02–1.06 0 (0.0) .610 1.06 1.03–1.09
 Pelvic pain 0 (0.0) 1.000 0.58 0.07–4.66 3 (17.6) .713 1.35 0.36–5.04 6 (5.5) .188 0.58 0.18–1.85 4 (3.7) .313 0.53 0.17–1.68
 Anal pain 2 (2.6) 1.000 0.74 0.13–4.14 14 (18.2) .179 1.74 0.77–3.95 0 (0.0) 1.000 1.04 1.02–1.07 0 (0.0) .614 1.06 1.03–1.09



Clinical findings
 Anal fissureb 1 (1.6) .666 0.38 0.04–3.36 9 (14.1) .914 1.05 0.44–2.51
 Genital discharge 1 (20.0) .148 9.15 0.86–97.35 1 (20.0) .533 1.56 0.17–14.49 5 (4.7) .463 1.57 0.47–5.26 6 (5.6) .985 1.01 0.36–2.81
 Urethritis 1 (16.7) .175 7.28 0.71–74.35 1 (16.7) 1.000 1.24 0.14–11.03
 Cervicitis 3 (13.6) .037 5.43 1.33–22.14 3 (13.6) .114 3.03 0.80–11.48
 Painful anorectal examb 0 (0.0) .585 1.04 1.00–1.07 9 (25.0) .022 2.88 1.13–7.34
 Painful bimanual exam 2 (7.7) .270 2.28 0.47–11.15 0 (0.0) .382 1.07 1.04–1.11
 Viral load .650 2.52 0.27–23.03 .626 0.79 0.31–2.01 .020 0.20 0.05–0.78 .051 0.36 0.12–1.04
  ≤40 cp/mL 4 (4.0) 12 (11.9) 3 (1.7) 6 (3.3)
  >40 cp/mL 1 (1.6) 9 (14.5) 8 (7.8) 9 (7.8)
 CD4+ ≤500 cells/μL 1 (1.7) .653 0.42 0.05–3.84 10 (16.7) .271 1.67 0.66–4.21 3 (3.6) 1.000 0.92 0.24–3.55 7 (8.4) .178 1.99 0.72–5.55
 No ART in use 1 (2.94) 1.000 1.07 0.12–9.48 5 (14.7) .894 0.93 0.33–2.66 5 (10.0) .008 0.22 0.06–0.74 5 (10.0) .136 0.44 0.15–1.32

CT/NG indicates chlamydia and/or gonorrhea infection.

a

MW, minimum wage ≈$194.

b

Investigation on anal fissure and painful anorectal exam were only performed by the proctologist in male patients.